As the decade comes to an end, we’ve asked Xconomists and other technology leaders around the country to identify the top innovations they’ve seen in their fields the past 10 years, or predict the top disruptive technologies that will impact the next decade.
- Increasing use, validation and acceptance of surrogate endpoints for clinical trials.
- Novartis’ imatinib (Gleevec). The first drug for specifically inhibiting an enzyme causing cancer rather than killing fast dividing cells….
- Human papillomavirus vaccines. This is both for innovative science, and innovative treatment of a vaccine for a virus tied to cancer.
Information is Stored in the Code Letters of DNA
- All hereditary information is stored in genes, which are parts of giant DNA molecules
- Genes code for the amino acids of proteins
- DNA is the archival copy of the code- kept in nucleus where it is protected & repaired
- DNA is organized with special proteins into chromosomes
- For protein synthesis a working copy of the code is made from RNA
- Overall scheme: DNA -> RNA -> protein
- Another version: “One gene, one enzyme”
Related articles by Zemanta
- New Compound Shrinks Skin Cancers (nlm.nih.gov)
A team of experts at the Yale University has recently announced that it has developed a new series of nanosensors, a class of devices that is able to analyze whole blood samples, and detect the presence of cancer biomarkers in them. The latter are chemical agents that tumors and cancer cells produce, and their existence in the body can only mean one thing. The amazing achievement could soon enable physicians to cut the cancer-detection process short, leaving more time for the actual treatments.
Scientists from University of Strathclyde have devised a novel way to harness natural vitamin E extract that would kill tumours within 10 days.
Using a new delivery system, the research team could mobilise an extract from Vitamin E, known ton have anti-cancer properties, to attack cancerous cells.
In the study conducted over skin cancer, the researchers found that tumours started to shrink within 24 hours and almost vanished in ten days.
They believe the tumours might have been completely destroyed if the tests had continued for longer.
When the tumours regrew, they did so at a far slower rate than previously.